Time to improve the reporting of harms in randomized controlled trials

被引：44

作者：

Junqueira, Daniela R. ^{[1
]}

Phillips, Rachel ^{[2
]}

Zorzela, Liliane ^{[3
]}

Golder, Su ^{[4
]}

Loke, Yoon ^{[5
]}

Moher, David ^{[6
,7
]}

Ioannidis, John P. A. ^{[8
,9
,10
,11
]}

Vohra, Sunita ^{[12
]}

机构：

[1] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada

[2] Imperial Coll London, Sch Publ Hlth, Fac Med, London, England

[3] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada

[4] Univ York, Dept Hlth Sci, York, N Yorkshire, England

[5] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England

[6] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada

[7] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada

[8] Stanford Univ, Dept Med, Stanford, CA 94305 USA

[9] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA

[10] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA

[11] Stanford Univ, Dept Stat, Stanford, CA 94305 USA

[12] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada

来源：

JOURNAL OF CLINICAL EPIDEMIOLOGY | 2021年 / 136卷

关键词：

QUALITY;

D O I：

10.1016/j.jclinepi.2021.04.020

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：216 / 220

页数：5

共 19 条

[1]

[Anonymous], 2021, CONSORT TRANSPARENT

[2] Reporting of Harm in Randomized Controlled Trials Published in the Urological Literature [J].

Breau, Rodney H. ;

Gaboury, Isabelle ;

Scales, Charles D., Jr. ;

Fesperman, Susan F. ;

Watterson, James D. ;

Dahm, Philipp .

JOURNAL OF UROLOGY, 2010, 183 (05) :1693-1697

[3] Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010 [J].

Califf, Robert M. ;

Zarin, Deborah A. ;

Kramer, Judith M. ;

Sherman, Rachel E. ;

Aberle, Laura H. ;

Tasneem, Asba .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (17) :1838-1847

[4] AHRQ Series Paper 4: Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program [J].

Chou, Roger ;

Aronson, Naomi ;

Atkins, David ;

Ismaila, Afisi S. ;

Santaguida, Pasqualina ;

Smith, David H. ;

Whitlock, Evelyn ;

Wilt, Timothy J. ;

Moher, David .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (05) :502-512

[5] Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice [J].

Cornelius, Victoria R. ;

Sauzet, Odile ;

Williams, John E. ;

Ayis, Salma ;

Farquhar-Smith, Paul ;

Ross, Joy R. ;

Branford, Ruth A. ;

Peacock, Janet L. .

PAIN, 2013, 154 (02) :213-220

[6] Adverse drug reactions: definitions, diagnosis, and management [J].

Edwards, IR ;

Aronson, JK .

LANCET, 2000, 356 (9237) :1255-1259

[7] Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension [J].

Hodkinson, Alex ;

Kirkham, Jamie J. ;

Tudur-Smith, Catrin ;

Gamble, Carrol .

BMJ OPEN, 2013, 3 (09)

[8] Completeness of safety reporting in randomized trials - An evaluation of 7 medical areas [J].

Ioannidis, JPA ;

Lau, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (04) :437-443

[9] Better reporting of harms in randomized trials: An extension of the CONSORT statement [J].

Ioannidis, JPA ;

Evans, SJW ;

Gotzsche, PC ;

O'Neill, RT ;

Altman, DG ;

Schulz, K ;

Moher, D .

ANNALS OF INTERNAL MEDICINE, 2004, 141 (10) :781-788

[10] Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective [J].

Lineberry, Neil ;

Berlin, Jesse A. ;

Mansi, Bernadette ;

Glasser, Susan ;

Berkwits, Michael ;

Klem, Christian ;

Bhattacharya, Ananya ;

Citrome, Leslie ;

Enck, Robert ;

Fletcher, John ;

Haller, Daniel ;

Chen, Tai-Tsang ;

Laine, Christine .

BMJ-BRITISH MEDICAL JOURNAL, 2016, 355

← 1 2 →